Published Healthcare & Pharmaceuticals Prostate Cancer Biomarker A methylated DNA classifier to identify prostate cancer with over 90% sensitivity and specificity By Queen’s University
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
